Astellas Europe Photos

Astellas investing in R&D in The Netherlands

+ Add Photo

Astellas Europe Reviews

Recommend to a friend
Approve of CEO
Astellas Europe CEO Yoshihiko Hatanaka
Yoshihiko Hatanaka
0 Ratings
  • Helpful (1)

    very good experience

    Current Employee - Anonymous Employee
    Current Employee - Anonymous Employee

    I have been working at Astellas Europe full-time


    corporate environment, high salaries, friendly environment


    too much bureaucracy, a long trip to the HQ

Astellas Europe Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Headquarters Chertsey, United Kingdom
Size 50 to 149 Employees
Founded 1990
Type Subsidiary or Business Segment
Industry Biotech & Pharmaceuticals
Revenue $100 to $500 million (USD) per year

Astellas Pharma Europe is one of the stars in Japanese drug firm Astellas' constellation. The company sells prescription pharmaceuticals for a variety of ailments, specializing in dermatology, urology, anti-infectives, and transplantation needs. Drugs in various stages in its pipeline include immunosuppressants targeting organ rejection and treatments for pancreatic cancer, irritable bowel syndrome, and Type 2 diabetes, among others. Astellas Pharma Global Development Europe is responsible for the company's R&D operations, which are housed in the Netherlands ... More

Work at Astellas Europe? Share Your Experiences

Astellas Europe

Click to Rate